Provided by Tiger Fintech (Singapore) Pte. Ltd.

HCW Biologics Inc.

0.2272
-0.0115-4.82%
Post-market: 0.23000.0028+1.23%19:59 EDT
Volume:197.63K
Turnover:45.13K
Market Cap:10.12M
PE:-0.29
High:0.2450
Open:0.2450
Low:0.2178
Close:0.2387
Loading ...

HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-in-Human Phase 1 Clinical Trial

THOMSON REUTERS
·
03 Feb

HCW Biologics Granted FDA Clearance to Evaluate One of the Company’s Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial

GlobeNewswire
·
03 Feb

HCW Biologics Insiders Placed Bullish Bets Worth US$2.50m

Simply Wall St.
·
23 Jan

HCW Biologics CEO to address opportunities, challenges in biomanufacturing

TIPRANKS
·
15 Jan

HCW Biologics’ Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

GlobeNewswire
·
15 Jan

HCW Biologics Shares Fall Amid Delisting Notice From Nasdaq

MT Newswires Live
·
24 Dec 2024

HCW Biologics receives notice on failing to regain compliance from Nasdaq

TIPRANKS
·
23 Dec 2024

HCW Biologics Inc. Received Nasdaq Staff Determination Letter

THOMSON REUTERS
·
23 Dec 2024

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

GlobeNewswire
·
23 Dec 2024

HCW Biologics Secures Strategic Agreements and Funding to Propel Growth and Innovation

TIPRANKS
·
27 Nov 2024

HCW Biologics Expands with New Financial Agreements

TIPRANKS
·
21 Nov 2024

HCW Biologics prices $6.9M registered direct offering at $1.03 per share

TipRanks
·
20 Nov 2024

HCW Biologics to Raise $6.9 Million in Gross Proceeds From Direct Offering, Private Placement; Shares Extend Gains Premarket

MT Newswires Live
·
19 Nov 2024

BRIEF-Hcw Biologics Prices $6.9 Mln Registered Direct Offering And Concurrent Private Placement At $1.03 Per Share

Reuters
·
19 Nov 2024

HCW Biologics Inc - Combined Effective Offering Price Set at $1.03 per Share

THOMSON REUTERS
·
19 Nov 2024

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under Nasdaq Rules

THOMSON REUTERS
·
19 Nov 2024

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

GlobeNewswire
·
19 Nov 2024

Top Midday Gainers

MT Newswires Live
·
19 Nov 2024

HCW Biologics Shares Surge on License Agreement

Dow Jones
·
19 Nov 2024

Why Is Penny Stock HCW Biologics Surging On Monday?

Benzinga
·
18 Nov 2024